NEUROSURGERY/CANCER DETECTION/PROTEOMICS: Regulators approve optical systems for biomedicine

May 1, 2013
Among recent regulatory approvals for bio-optics products are a second FDA 501(k) clearance for Monteris Medical's (Minneapolis, MN) MRI-guided laser ablation device for brain tumors and other lesions.

Among recent regulatory approvals for bio-optics products are a second FDA 501(k) clearance for Monteris Medical's (Minneapolis, MN) MRI-guided laser ablation device for brain tumors and other lesions. Called NeuroBlate, the device includes a surgical laser for ablation of diseased brain tissue, with updated visualization provided by active MRI. A first-generation version of the device has been available in U.S. hospitals since 2010. NeuroBlate supports surgical decision-making during brain operations and provides post-procedure confirmation of the effects of the thermal therapy.

The HER2 IQFISH pharmDx fluorescence in situ hybridization (FISH) assay, which could reduce cancer evaluation from 2 days to 3.5 hours, is the first system of its kind to receive FDA approval. Marketed by Dako (Glostrup, Denmark), an Agilent Technologies company, the system promises to enable faster, targeted cancer treatments.

IQFISH helps to assess patients for whom treatment with trastuzumab (a monoclonal antibody) is being considered. It can also support identification of HER2 gene status with accuracy and speed. The HER2 gene encodes a protein called human epidermal growth factor receptor 2 (HER2), which promotes cell growth and aggressiveness in one out of five breast cancers, which are less responsive to hormone treatment.

Finally, Genalyte's (San Diego, CA) Maverick multiplexed detection system, which simultaneously analyzes multiple antibodies and other proteins from a single small sample, is now CE-marked in Europe for research use. The system uses a silicon chip containing arrays of photonic ring sensors that simultaneously analyze multiple antibodies and other proteins. Its one-step workflow is said to deliver results in as little as 15 minutes from small-volume samples of many types.

About the Author

Barbara Gefvert | Editor-in-Chief, BioOptics World (2008-2020)

Barbara G. Gefvert has been a science and technology editor and writer since 1987, and served as editor in chief on multiple publications, including Sensors magazine for nearly a decade.

Sponsored Recommendations

March 31, 2025
Enhance your remote sensing capabilities with Chroma's precision-engineered optical filters, designed for applications such as environmental monitoring, geospatial mapping, and...
March 31, 2025
Designed for compatibility with a wide range of systems, Chroma's UV filters are engineered to feature high transmission, superior out-of-band blocking, steep edge transitions...
March 31, 2025
Discover strategies to balance component performance and system design, reducing development time and costs while maximizing efficiency.
March 31, 2025
Explore the essential role of optical filters in enhancing Raman spectroscopy measurements including the various filter types and their applications in improving signal-to-noise...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!